Olema Pharmaceuticals, Inc. (OLMA)
NASDAQ: OLMA · Real-Time Price · USD
7.07
+0.07 (1.00%)
At close: Nov 2, 2026, 4:00 PM EST
7.14
+0.07 (0.99%)
Pre-market: Nov 3, 2026, 6:49 AM EST
Olema Pharmaceuticals Employees
Olema Pharmaceuticals had 150 employees as of June 30, 2026. The number of employees increased by 33 or 28.21% compared to the same quarter last year. That makes Olema Pharmaceuticals the 28,850th largest employer in the world and 3,666th in the United States.
Employees
150
Change (1Y)
33
Growth (1Y)
28.21%
Revenue / Employee
n/a
Profits / Employee
-$1,363,780
Market Cap
618.61M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jun 30, 2026 | 150 | 33 | 28.21% | 150 | 0 |
| Mar 31, 2026 | 137 | 35 | 34.31% | 137 | 0 |
| Dec 31, 2025 | 131 | 35 | 36.46% | 131 | 0 |
| Sep 30, 2025 | 122 | 34 | 38.64% | 122 | 0 |
| Jun 30, 2025 | 117 | 28 | 31.46% | 116 | 1 |
| Mar 31, 2025 | 102 | 26 | 34.21% | 101 | 1 |
| Dec 31, 2024 | 96 | 22 | 29.73% | 96 | 0 |
| Sep 30, 2024 | 88 | 18 | 25.71% | 87 | 1 |
| Jun 30, 2024 | 89 | 17 | 23.61% | 80 | 9 |
| Mar 31, 2024 | 76 | 13 | 20.63% | 75 | 1 |
| Dec 31, 2023 | 74 | -12 | -13.95% | 74 | 0 |
| Sep 30, 2023 | 70 | -5 | -6.67% | 70 | 0 |
| Jun 30, 2023 | 72 | -3 | -4.00% | 67 | 5 |
| Mar 31, 2023 | 63 | -8 | -11.27% | 62 | 1 |
| Dec 31, 2022 | 86 | 12 | 16.22% | 83 | 3 |
| Sep 30, 2022 | 75 | 14 | 22.95% | 73 | 2 |
| Jun 30, 2022 | 75 | 24 | 47.06% | 72 | 3 |
| Mar 31, 2022 | 71 | 34 | 91.89% | 70 | 1 |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Geron | 258 |
| 4D Molecular Therapeutics | 196 |
| Aura Biosciences | 113 |
| Adlai Nortye Group | 109 |
| Lexicon Pharmaceuticals | 81 |
| Zevra Therapeutics | 61 |
| Candel Therapeutics | 55 |
| Design Therapeutics | 55 |
OLMA News
- 14 hours ago - Olema Oncology to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 4 weeks ago - Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 6 weeks ago - Olema Pharmaceuticals Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 6 weeks ago - Olema Pharmaceuticals Transcript: Morgan Stanley 24th Annual Global Healthcare Conference - Transcripts
- 7 weeks ago - Olema Oncology price target lowered to $30 from $48 at Stifel - TheFly
- 7 weeks ago - Olema selloff on Astra miss ‘significant overreaction,’ says JPMorgan - TheFly
- 7 weeks ago - Olema selloff on AstraZeneca miss a buying opportunity, says Citi - TheFly
- 7 weeks ago - Olema Pharmaceuticals Transcript: Citigroup’s Biopharma Back to School Summit 2026 - Transcripts